These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23923282)

  • 41. Metabolic syndrome and type 2 diabetes: lipid and physiological consequences.
    Chapman MJ
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S5-8. PubMed ID: 17935058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Total sialic acid and associated elements of the metabolic syndrome in women with and without previous gestational diabetes.
    Sriharan M; Reichelt AJ; Opperman ML; Duncan BB; Mengue SS; Crook MA; Schmidt MI
    Diabetes Care; 2002 Aug; 25(8):1331-5. PubMed ID: 12145230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current evidence on the health-beneficial effects of berry fruits in the prevention and treatment of metabolic syndrome.
    Kowalska K; Olejnik A
    Curr Opin Clin Nutr Metab Care; 2016 Nov; 19(6):446-452. PubMed ID: 27583706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The metabolic syndrome: recognition and management.
    Hall WD; Watkins LO; Wright JT; Wenger NK; Kumanyika SK; Gavin JR; Ferdinand KC; Watson K; Clark LT; Flack JM; Reed JW; Horton EW; Saunders E;
    Dis Manag; 2006 Feb; 9(1):16-33. PubMed ID: 16466339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.
    Leiter LA; Lundman P; da Silva PM; Drexel H; Jünger C; Gitt AK;
    Diabet Med; 2011 Nov; 28(11):1343-51. PubMed ID: 21679231
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome? Comment on the article by Yasuda et al.
    Oda E
    Endocr J; 2007 Dec; 54(6):1033. PubMed ID: 17984571
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autoimmune vasculitis and plaque erosion in the cardiometabolic syndrome and type 2 diabetes mellitus.
    Hayden MR; Karuparthi PR; Chowdhury NA; Govindarajan G; Habibi J; Ortmann RA
    J Cardiometab Syndr; 2006; 1(3):228-32. PubMed ID: 17679803
    [No Abstract]   [Full Text] [Related]  

  • 49. [Dyslipidemia in diabetes mellitus: diagnosis and treatment].
    Oikawa S
    Nihon Rinsho; 2015 Dec; 73(12):2079-83. PubMed ID: 26666156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Practical implications for clinical monitoring.
    Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):87-9. PubMed ID: 19667658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The use of insulin-modified intravenous glucose tolerance test in the diagnosis of insulin resistance in patients with metabolic syndrome].
    Ias'kova KN; Mychka VB; Masenko VP; Chazova IE; Tvorogova MG
    Klin Lab Diagn; 2003 Nov; (11):13-5. PubMed ID: 14708365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for common clinical conditions in older women.
    Thakur SS; Supiano MA
    Clin Obstet Gynecol; 2007 Sep; 50(3):767-75. PubMed ID: 17762424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus.
    Brunzell JD; Ayyobi AF
    Am J Med; 2003 Dec; 115 Suppl 8A():24S-28S. PubMed ID: 14678862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum.
    Ascaso J; Gonzalez Santos P; Hernandez Mijares A; Mangas Rojas A; Masana L; Millan J; Pallardo LF; Pedro-Botet J; Perez Jimenez F; Pintó X; Plaza I; Rubiés J; Zúñiga M
    Am J Cardiovasc Drugs; 2007; 7(1):39-58. PubMed ID: 17355165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
    Rossing K
    Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525
    [No Abstract]   [Full Text] [Related]  

  • 56. [Efficacy of exercise therapy to reduce cardiometabolic risk factors in overweight and obese children and adolescents: a systematic review].
    Blohm D; Ploch T; Apelt S
    Dtsch Med Wochenschr; 2012 Dec; 137(50):2631-6. PubMed ID: 23225186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Multiple skin papules of the axilla. What metabolic disorder should be considered?].
    Winter M
    MMW Fortschr Med; 2007 May; 149(22):5. PubMed ID: 18069219
    [No Abstract]   [Full Text] [Related]  

  • 58. Dyslipidemia.
    ; Mancini GBJ; Hegele RA; Leiter LA
    Can J Diabetes; 2018 Apr; 42 Suppl 1():S178-S185. PubMed ID: 29650093
    [No Abstract]   [Full Text] [Related]  

  • 59. [Latin American consensus on hypertension in patients with diabetes type 2 and metabolic syndrome].
    López-Jaramillo P; Sánchez RA; Diaz M; Cobos L; Bryce A; Parra-Carrillo JZ; Lizcano F; Lanas F; Sinay I; Sierra ID; Peñaherrera E; Bendersky M; Schmid H; Botero R; Urina M; Lara J; Foss MC; Márquez G; Harrap S; Ramírez AJ; Zanchetti A;
    Arq Bras Endocrinol Metabol; 2014 Apr; 58(3):205-25. PubMed ID: 24863082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus.
    Qualls LG; Hammill BG; Maciejewski ML; Curtis LH; Jones WS
    Diab Vasc Dis Res; 2016 May; 13(3):244-6. PubMed ID: 26802221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.